Additionally, a recent paper reported that the inhibition of NUAK1 enhances cisplatin cytotoxicity in NSCLC cells suggesting that also in breast cancer NUAK1 could represent a novel target against drug resistance.85 This evidence concerns the gene NUAK1 and non-small cell lung carcinoma.